Priya Singhal - 06 Feb 2026 Form 4 Insider Report for BIOGEN INC. (BIIB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Feb 2026, 17:05:47 UTC
Prior SEC filing
03 Feb 2026
Next SEC filing
17 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Wendell Taylor, attorney-in-fact for Priya Singhal

Key filing fact

Priya Singhal filed Form 4 for BIOGEN INC. (BIIB) on 10 Feb 2026.

Key facts

  • This page summarizes Priya Singhal's Form 4 filing for BIOGEN INC. (BIIB).
  • 7 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 10 Feb 2026, 17:05.

Change

  • Previous filing in this sequence was filed on 03 Feb 2026.
  • Current net transaction value: -$1,028,060.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001769608 Primary reporting owner

Singhal Priya

Relationship
Head of Development
Address
225 BINNEY, CAMBRIDGE
Signature
/s/ Wendell Taylor, attorney-in-fact for Priya Singhal
Signature date
10 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIIB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+2,217
Change %
+35%
Price
$0.000000
Shares after
8,488
Date
06 Feb 2026
Ownership
Direct
BIIB transaction

Common Stock

Tax liability

Transaction value
$212,446
Shares
-1,056
Change %
-12%
Price
$201.18
Shares after
7,432
Date
06 Feb 2026
Ownership
Direct
BIIB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+4,683
Change %
+63%
Price
$0.000000
Shares after
12,115
Date
06 Feb 2026
Ownership
Direct
BIIB transaction

Common Stock

Tax liability

Transaction value
$284,066
Shares
-1,412
Change %
-12%
Price
$201.18
Shares after
10,703
Date
06 Feb 2026
Ownership
Direct
BIIB transaction

Common Stock

Sale

Transaction value
$531,548
Shares
-2,660
Change %
-25%
Price
$199.83
Shares after
8,043
Date
09 Feb 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIIB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-2,217
Change %
-50%
Price
$0.000000
Shares after
2,217
Date
06 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,217
Exercise price
$0.000000
Footnotes
F1
BIIB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-4,683
Change %
-33%
Price
$0.000000
Shares after
9,367
Date
06 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,683
Exercise price
$0.000000
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Footnote F2

The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .